These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6690689)

  • 21. The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain.
    Neff NH; Yang HY; Fuentes JA
    Adv Biochem Psychopharmacol; 1974; 12(0):49-57. PubMed ID: 4609330
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of monoamine oxidases. Effect of triton X-100 and bile salts on monoamine oxidase in brain mitochondria.
    Achee FM; Gabay S
    Biochem Pharmacol; 1981 Dec; 30(23):3151-7. PubMed ID: 7317100
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of selective monoamine oxidase inhibitors on rat brain mitochondrial monoamine oxidase during hyperbaric oxygenation.
    Goroshinskaya IA; Bronovizkaya ZG; Gorkin VZ
    Commun Psychopharmacol; 1977; 1(1):39-47. PubMed ID: 606471
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition patterns of monoamine oxidase in sub-fractions of rat brain mitochondria in presence of some selective inhibitors.
    Mitra C; Guha SR
    Biochem Pharmacol; 1979 Apr; 28(7):1135-7. PubMed ID: 444271
    [No Abstract]   [Full Text] [Related]  

  • 25. Monoamine oxidase: examination of multiple forms.
    Jain M
    Life Sci; 1977 Jun; 20(12):1925-33. PubMed ID: 329033
    [No Abstract]   [Full Text] [Related]  

  • 26. Monoamine oxidases: versatility of catalytic properties and possible biological functions.
    Gorkin VZ
    Adv Pharmacol Chemother; 1973; 11():1-50. PubMed ID: 4201892
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
    Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
    Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cimoxatone is a reversible tight-binding inhibitor of the A form of rat brain monoamine oxidase.
    Fowler CJ; Strolin Benedetti M
    J Neurochem; 1983 Feb; 40(2):510-3. PubMed ID: 6822834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of monoamine oxidase in mitochondria isolated from chick brain, liver, kidney and heart.
    Suzuki O; Hattori H; Oya M; Katsumata Y
    Biochem Pharmacol; 1980 Feb; 29(4):603-7. PubMed ID: 7370053
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro inhibition of brain mitochondrial monoamine oxidase by 6-hydroxydopamine.
    Youdim MB
    Br J Pharmacol; 1975 Jul; 54(3):403-5. PubMed ID: 1164597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procaine HCl (Gerovital H3): a weak, reversible, fully competitive inhibitor of monoamine oxidase.
    MacFarlane MD
    Fed Proc; 1975 Jan; 34(1):108-10. PubMed ID: 1109354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoamine oxidase. I. Specificity of some substrates and inhibitors.
    Williams CH
    Biochem Pharmacol; 1974 Feb; 23(3):615-28. PubMed ID: 4822746
    [No Abstract]   [Full Text] [Related]  

  • 33. Variations in mitochondrial monoamine oxidase during progressive starvation in the brain of developing rats.
    Ismahan G; Parvez H; Parvez S
    Biochim Biophys Acta; 1979 May; 584(2):196-202. PubMed ID: 435508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.
    Hassan SY; Khattab SN; Bekhit AA; Amer A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some considerations in the design of substrate and tissue-specific inhibitors of monoamine oxidase.
    Martin YC; Biel JH
    Adv Biochem Psychopharmacol; 1974; 12(0):37-48. PubMed ID: 4417042
    [No Abstract]   [Full Text] [Related]  

  • 36. Binding of [14C] allylamine to isolated mitochondria from rat heart and aorta.
    Hysmith RM; Boor PJ
    Toxicology; 1987 Apr; 44(1):13-29. PubMed ID: 3105119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychoactive drug effects and substrate-specificity in intact mitochondrial monoamine oxidase from brain [proceedings].
    Gabay S; Achee FM
    Psychopharmacol Bull; 1977 Jan; 13(1):45-6. PubMed ID: 13452
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
    J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human brain monoamine oxidase: multiple forms and selective inhibitors.
    Youdim MB; Collins GG; Sandler M; Bevan Jones AB; Pare CM; Nicholson WJ
    Nature; 1972 Mar; 236(5344):225-8. PubMed ID: 4553640
    [No Abstract]   [Full Text] [Related]  

  • 40. Confluentic acid and 2'-O-methylperlatolic acid, monoamine oxidase B inhibitors in a Brazilian plant, Himatanthus sucuuba.
    Endo Y; Hayashi H; Sato T; Maruno M; Ohta T; Nozoe S
    Chem Pharm Bull (Tokyo); 1994 Jun; 42(6):1198-201. PubMed ID: 8069971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.